Patents by Inventor Charles Bates

Charles Bates has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12030923
    Abstract: The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof. The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.
    Type: Grant
    Filed: November 25, 2020
    Date of Patent: July 9, 2024
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kirk J. Leister, Eugene J. Schaefer, Ronald Charles Bates, Elizabeth A. Bramhall, David Michael Didio, Robert Donaldson, Alan R. Flesher, Helen Gray Haggerty, David Henry Kirkley, John Malcolm Tabor, Lee K. Tay, Pallaiah Thammana, Ajoy Velayudhan, David Edward Smolin, Reb J. Russell, Thomas James Vanden Boom, Dean Woodrow Brownell, Jeffrey Schrimsher, Joyce Patricia Whitehead
  • Publication number: 20210246188
    Abstract: The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof. The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.
    Type: Application
    Filed: November 25, 2020
    Publication date: August 12, 2021
    Applicant: Bristol-Myers Squibb Company
    Inventors: Kirk J. Leister, Eugene J. Schaefer, Ronald Charles Bates, Elizabeth A. Bramhall, David Michael Didio, Robert Donaldson, Alan R. Flesher, Helen Gray Haggerty, David Henry Kirkley, John Malcolm Tabor, Lee K. Tay, Pallaiah Thammana, Ajoy Velayudhan, David Edward Smolin, Reb J. Russell, Thomas James Vanden Boom, Dean Woodrow Brownell, Jeffrey Schrimsher, Joyce Patricia Whitehead
  • Patent number: 10941189
    Abstract: The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof. The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: March 9, 2021
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kirk J. Leister, Eugene J. Schaefer, Ronald Charles Bates, Elizabeth A. Bramhall, David Michael Didio, Robert Donaldson, Alan R. Flesher, Helen Gray Haggerty, David Henry Kirkley, John Malcolm Tabor, Lee K. Tay, Pallaiah Thammana, Ajoy Velayudhan, David Edward Smolin, Reb J. Russell, Thomas James Vanden Boom, Dean Woodrow Brownell, Jeffrey Schrimsher, Joyce Patricia Whitehead
  • Patent number: 10851150
    Abstract: The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof. The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: December 1, 2020
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kirk J. Leister, Eugene J. Schaefer, Ronald Charles Bates, Elizabeth A. Bramhall, David Michael Didio, Robert Donaldson, Alan R. Flesher, Helen Gray Haggerty, David Henry Kirkley, John Malcolm Tabor, Lee K. Tay, Pallaiah Thammana, Ajoy Velayudhan, David Edward Smolin, Reb J. Russell, Thomas James Vanden Boom, Dean Woodrow Brownell, Jeffrey Schrimsher, Joyce Patricia Whitehead
  • Patent number: 10808021
    Abstract: The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof. The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: October 20, 2020
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kirk J. Leister, Eugene J. Schaefer, Ronald Charles Bates, Elizabeth A. Bramhall, David Michael Didio, Robert Donaldson, Alan R. Flesher, Helen Gray Haggerty, David Henry Kirkley, John Malcolm Tabor, Lee K. Tay, Pallaiah Thammana, Ajoy Velayudhan, David Edward Smolin, Reb J. Russell, Thomas James Vanden Boom, Dean Woodrow Brownell, Jeffrey Schrimsher, Joyce Patricia Whitehead
  • Publication number: 20200017569
    Abstract: The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.
    Type: Application
    Filed: July 24, 2018
    Publication date: January 16, 2020
    Inventors: Kirk J. Leister, Eugene J. Schaefer, Ronald Charles Bates, Elizabeth A. Bramhall, David Michael Didio, Robert Donaldson, Alan R. Flesher, Helen Gray Haggerty, David Henry Kirkley, John Malcolm Tabor, Lee K. Tay, Pallaiah Thammana, Ajoy Velayudhan, David Edward Smolin, Reb J. Russell, Thomas James Vanden Boom, Dean Woodrow Brownell, Jeffrey Schrimsher, Joyce Patricia Whitehead
  • Patent number: 10508144
    Abstract: The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof. The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.
    Type: Grant
    Filed: December 19, 2006
    Date of Patent: December 17, 2019
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kirk J. Leister, Eugene J. Schaefer, Ronald Charles Bates, Elizabeth A. Bramhall, David Michael Didio, Robert Donaldson, Alan R. Flesher, Helen Gray Haggerty, David Henry Kirkley, John Malcolm Tabor, Lee K. Tay, Pallaiah Thammana, Ajoy Velayudhan, David Edward Smolin, Reb J. Russell, Thomas James Vanden Boom, Dean Woodrow Brownell, Jeffrey Schrimsher, Joyce Patricia Whitehead
  • Publication number: 20190092835
    Abstract: The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof. The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.
    Type: Application
    Filed: July 24, 2018
    Publication date: March 28, 2019
    Inventors: Kirk J. Leister, Eugene J. Schaefer, Ronald Charles Bates, Elizabeth A. Bramhall, David Michael Didio, Robert Donaldson, Alan R. Flesher, Helen Gray Haggerty, David Henry Kirkley, John Malcolm Tabor, Lee K. Tay, Pallaiah Thammana, Ajoy Velayudhan, David Edward Smolin, Reb J. Russell, Thomas James Vanden Boom, Dean Woodrow Brownell, Jeffrey Schrimsher, Joyce Patricia Whitehead
  • Publication number: 20190092836
    Abstract: The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.
    Type: Application
    Filed: July 24, 2018
    Publication date: March 28, 2019
    Inventors: Kirk J. Leister, Eugene J. Schaefer, Ronald Charles Bates, Elizabeth A. Bramhall, David Michael Didio, Robert Donaldson, Alan R. Flesher, Helen Gray Haggerty, David Henry Kirkley, John Malcolm Tabor, Lee K. Tay, Pallaiah Thammana, Ajoy Velayudhan, David Edward Smolin, Reb J. Russell, Thomas James Vanden Boom, Dean Woodrow Brownell, Jeffrey Schrimsher, Joyce Patricia Whitehead
  • Publication number: 20190062399
    Abstract: The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof. The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.
    Type: Application
    Filed: July 23, 2018
    Publication date: February 28, 2019
    Inventors: Kirk J. Leister, Eugene J. Schaefer, Ronald Charles Bates, Elizabeth A. Bramhall, David Michael Didio, Robert Donaldson, Alan R. Flesher, Helen Gray Haggerty, David Henry Kirkley, John Malcolm Tabor, Lee K. Tay, Pallaiah Thammana, Ajoy Velayudhan, David Edward Smolin, Reb J. Russell, Thomas James Vanden Boom, Dean Woodrow Brownell, Jeffrey Schrimsher, Joyce Patricia Whitehead
  • Patent number: 9882361
    Abstract: An active cover plate is disclosed. The active cover plate may include a face plate, a back plate; an electrical load, at least one clip may extend rearward from the face plate and a wall may extend rearward from the back plate, where the wall may cover at least a part of a rear of the clip, and an electrical connection may connect the electrical load to the clip.
    Type: Grant
    Filed: April 6, 2017
    Date of Patent: January 30, 2018
    Inventors: Jeremy Smith, Phil Dietz, Martin Johnson, Beau Oyler, Jeff Tung, Julian Bagirov, Charles Bates, Darren Knight
  • Patent number: 9882318
    Abstract: A wall-plate system is disclosed. The wall-plate system may include a face plate, a back plate, electronic circuitry comprising an electrical port, a clip, and a conductor. The face plate may have a front, a back, and at least one outlet aperture. The back plate may abut the back of the face plate and have a wall extending rearward away from the face plate. The clip may connect to the face plate and extend rearward away from the back of the face plate. The clip may be positioned laterally inboard of the wall and resiliently deflect from a neutral position spaced from the wall to a deflected position in contact with the wall. The conductor may be sandwiched between the face plate and the back plate and extend to electrically connect the clip to the electronic circuitry.
    Type: Grant
    Filed: April 6, 2017
    Date of Patent: January 30, 2018
    Inventors: Jeremy Smith, Phil Dietz, Martin Johnson, Beau Oyler, Jeff Tung, Julian Bagirov, Charles Bates, Darren Knight
  • Publication number: 20170214229
    Abstract: An active cover plate is disclosed. The active cover plate may include a face plate, a back plate; an electrical load, at least one clip may extend rearward from the face plate and a wall may extend rearward from the back plate, where the wall may cover at least a part of a rear of the clip, and an electrical connection may connect the electrical load to the clip.
    Type: Application
    Filed: April 6, 2017
    Publication date: July 27, 2017
    Inventors: Jeremy Smith, Phil Dietz, Martin Johnson, Beau Olyer, Jeff Tung, Julian Bagirov, Charles Bates, Darren Knight
  • Publication number: 20170214188
    Abstract: A wall-plate system is disclosed. The wall-plate system may include a face plate, a back plate, electronic circuitry comprising an electrical port, a clip, and a conductor. The face plate may have a front, a back, and at least one outlet aperture. The back plate may abut the back of the face plate and have a wall extending rearward away from the face plate. The clip may connect to the face plate and extend rearward away from the back of the face plate. The clip may be positioned laterally inboard of the wall and resiliently deflect from a neutral position spaced from the wall to a deflected position in contact with the wall. The conductor may be sandwiched between the face plate and the back plate and extend to electrically connect the clip to the electronic circuitry.
    Type: Application
    Filed: April 6, 2017
    Publication date: July 27, 2017
    Inventors: Jeremy Smith, Phil Dietz, Martin Johnson, Beau Olyer, Jeff Tung, Julian Bagirov, Charles Bates, Darren Knight
  • Patent number: D752930
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: April 5, 2016
    Assignee: THE AMES COMPANIES, INC.
    Inventors: Aaron Abbott, Jared Aller, Beau Oyler, Yulian Bagirov, Charles Bates
  • Patent number: D758162
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: June 7, 2016
    Assignee: The Ames Companies, Inc.
    Inventors: Aaron Abbott, Jared Aller, Beau Oyler, Yulian Bagirov, Charles Bates
  • Patent number: D760562
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: July 5, 2016
    Assignee: The Ames Companies, Inc.
    Inventors: Aaron Abbott, Jared Aller, Beau Oyler, Yulian Bagirov, Charles Bates
  • Patent number: RE46168
    Abstract: Applying services to calls involving subscribers to a telephony services provider includes receiving an indication of a call placed to or from a first call participant. The indication is received by a telephony services provider over a first signaling path of the call that is established between the telephony services provider and a first telephony proxy server that is controlled by a telephony infrastructure provider. Control signals configured to affect a voice path of the call that is established between the first telephony proxy server and a second telephony proxy server also controlled by the telephony infrastructure provider but associated with a second call participant are identified. The identified control signals are sent to the first telephony proxy server over the first signaling path and to the second telephony proxy server over a second signaling path that is established between the telephony services provider and the second telephony proxy server.
    Type: Grant
    Filed: July 20, 2012
    Date of Patent: September 27, 2016
    Assignee: FACEBOOK, INC.
    Inventor: Peter Charles Bates
  • Patent number: D778696
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: February 14, 2017
    Assignee: The Ames Companies, Inc.
    Inventors: Aaron Abbott, Jared Aller, Beau Oyler, Yulian Bagirov, Charles Bates
  • Axe
    Patent number: D831460
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: October 23, 2018
    Assignee: The Ames Companies, Inc.
    Inventors: Aaron Abbott, Jared Aller, Beau Oyler, Yulian Bagirov, Charles Bates